Inogen, Inc. (INGN)
- Previous Close
6.90 - Open
6.88 - Bid 6.99 x 100
- Ask 7.10 x 100
- Day's Range
6.72 - 7.07 - 52 Week Range
4.13 - 14.10 - Volume
177,396 - Avg. Volume
543,141 - Market Cap (intraday)
166.006M - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
-- - EPS (TTM)
-4.42 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.50
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
www.inogen.comRecent News: INGN
Performance Overview: INGN
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INGN
Valuation Measures
Market Cap
162.47M
Enterprise Value
55.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.51
Price/Book (mrq)
0.79
Enterprise Value/Revenue
0.18
Enterprise Value/EBITDA
-0.96
Financial Highlights
Profitability and Income Statement
Profit Margin
-32.46%
Return on Assets (ttm)
-10.91%
Return on Equity (ttm)
-40.80%
Revenue (ttm)
315.66M
Net Income Avi to Common (ttm)
-102.45M
Diluted EPS (ttm)
-4.42
Balance Sheet and Cash Flow
Total Cash (mrq)
128.47M
Total Debt/Equity (mrq)
10.70%
Levered Free Cash Flow (ttm)
4.72M
Research Analysis: INGN
Company Insights: INGN
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: INGN
INGN: Lowering target price to $8.00
INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetINGN: Raising target price to $9.00
INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetINGN: Lowering target price to $8.00
INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetINGN: What does Argus have to say about INGN?
INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target